Sep 03, 2009 (SmarTrend(R) News Watch via COMTEX) ----9/3/2009-In an effort to expand its foothold in the US market, Japan-based drug company Dainippon Sumitomo Pharma Co.

and Sepracor Inc.

(NASDAQ:SEPR) announced Thursday that they entered into a definitive agreement in which DSP will acquire Sepracor in a deal valued at $2.6 billion through a cash tender offer of $23.00 per share.

The cash offer represents a 48.0% premium over Sepracor's average stock price over the last six months and a 27.6% premium over the company's closing value Wednesday.

The transaction was unanimously approved by the Boards of Directors of both companies.

Mr.

Masayo Tada, President of DSP, noted, "Sepracor has pursued growth through development of its unique pipeline and introduction of innovative pharmaceutical products to the market, a strategy that fits perfectly with our management philosophy.

We expect that Sepracor will become a 'Center of Excellence' for DSP in the U.S., and will make a significant contribution to DSP both as a commercialization infrastructure for our self-developed products and as a strategically important base for business development." Write to Chip Brian at cbrian@tradethetrend.com --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time.

To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter.

Sign up at: http://www.TradeTheTrend.com/signup.html Copyright, Comtex News Network, Inc.

2009

http://www.foxbusiness.com/story/markets/industries/health-care/dainippon-acquires-sepracor--billion-sepr/